However, it is worth noting that PARP12, a mono-ADP-ribosyltransferase, was recently found to stabilize FHL2 and decrease the TGF-β1 expression level, inhibiting HCC cell EMT and metastasis [81]. Here, TGFB1 is linked to hepatocellular carcinoma.